2025

Oil Prices Fluctuate Amidst Geopolitical Uncertainty Market Volatility The oil market has been experiencing heightened volatility as geopolitical risks and supply concerns continue to impact prices. Currently, oil is struggling to stay above the $75 mark, with fluctuations in the market causing uncertainty among investors and consumers alike. Geopolitical Risks The ongoing tensions in the…

Morgan Stanley Upgrades Rating on LVMH to ‘Overweight’ Investment bank Morgan Stanley has raised its rating on French luxury goods giant LVMH to ‘overweight’ from ‘equal weight’. This move comes as a surprise to many investors, as LVMH has been a consistent performer in the luxury goods sector for years. So, what does this upgrade…

Endeavour Announces Transaction in Own Shares London, 27 January 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase: 24 January 2025 Aggregate number of ordinary shares of USD 0.01 each…

Welcome to the Blog Post! Seizing Generational Opportunities with GXO Recurring Revenue, Robot Armies, and CEO Drama: A Recipe for Success Hey there, fellow investors and trend-watchers! Let’s dive into the exciting world of GXO Logistics – a company that’s been making waves with its innovative approach to logistics and supply chain management. With a…

Roche Announces Positive Results from Year Two of EMBARK Trial A Game-Changer in the Treatment of Duchenne Muscular Dystrophy Basel, 27 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive topline results from year two of the EMBARK trial, a global, randomised, double-blind phase III study of Elevidys™ (delandistrogene moxeparvovec), the first…